Additionally, TGF-β is reported to increase fibroblast growth factor-2 (FGF-2) production and mesenchymal stem cell (MSC) differentiation into myofibroblasts to trigger cancer proliferation and invasiveness [25,26]. Here, FGF2 is linked to cancer.